AbbVie
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AbbVie generated cash of $22,839,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$17,222,000,000 last year. Net change in cash is therefore $3,613,000,000.
Cash Flow
| 2014 | 3.54B | -926M | -3.29B |
|---|---|---|---|
| 2015 | 7.53B | -12.93B | 5.75B |
| 2016 | 7.04B | -6.07B | -3.92B |
| 2017 | 9.96B | -274M | -5.51B |
| 2018 | 13.42B | -1.00B | -14.39B |
| 2019 | 13.32B | 596M | 18.70B |
| 2020 | 17.58B | -37.55B | -11.50B |
| 2021 | 22.77B | -2.34B | -19.03B |
| 2022 | 24.94B | -623M | -24.80B |
| 2023 | 22.83B | -2.00B | -17.22B |
0QCV.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.20B | 9.74B | 8.44B | 39.92B | 7.28B | 9.30B | 5.1B | 8.39B | 8.34B | 9.59B |
Operating activities | ||||||||||
Net income | 4.86B | 11.83B | 11.54B | 4.61B | 7.88B | 5.68B | 5.30B | 5.95B | 5.14B | 1.77B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.69B | 8.46B | 8.52B | 6.47B | 2.01B | 1.76B | 1.50B | 1.18B | 836M | 786M |
Stock-based compensation expense | 747M | 671M | 692M | 753M | 430M | 421M | 365M | 396M | 282M | 241M |
| Deferred income tax benefit | 747M | 671M | 692M | 753M | 430M | 421M | 365M | 396M | 282M | 241M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 66M | -1.45B | -1.32B | -929M | -74M | -591M | -391M | -71M | -1.07B | -172M |
Inventories | -417M | -686M | -142M | -40M | -231M | -226M | 93M | -38M | -434M | -203M |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 22.83B | 24.94B | 22.77B | 17.58B | 13.32B | 13.42B | 9.96B | 7.04B | 7.53B | 3.54B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -777M | -695M | -787M | -798M | -552M | -638M | -529M | -479M | -532M | -612M |
Acquisitions Net | -1.22B | -794M | -1.90B | -39.61B | -1.13B | -736M | -308M | -2.75B | -12.45B | -622M |
Cash generated by investing activities | -2.00B | -623M | -2.34B | -37.55B | 596M | -1.00B | -274M | -6.07B | -12.93B | -926M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 15.92B | 10.34B | 6.66B | 2.16B | 18.04B | 1.43B | 12.04B | 11.60B | 682M |
Payments for dividends | -10.53B | -10.04B | -9.26B | -7.71B | -6.36B | -5.58B | -4.10B | -3.71B | -3.29B | -2.66B |
Repurchases of common stock | -1.97B | -1.48B | -934M | -978M | -629M | -12.01B | -1.41B | -6.03B | -7.58B | -665M |
Repayments of term debt | -4.14B | -12.43B | -8.41B | -2.68B | 29.94B | -72M | -25M | -5.61B | 16.64B | -17M |
Cash used in financing activities | -17.22B | -24.80B | -19.03B | -11.50B | 18.70B | -14.39B | -5.51B | -3.92B | 5.75B | -3.29B |
Net Change In Cash | 3.61B | -545M | 1.29B | -31.47B | 32.63B | -2.01B | 4.20B | -3.29B | 51M | -1.24B |
Cash at end of period | 12.81B | 9.20B | 9.74B | 8.44B | 39.92B | 7.28B | 9.30B | 5.1B | 8.39B | 8.34B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |